Chihiro Hasegawa1,2, Stephen B Duffull1. Show Affiliations » 1. School of Pharmacy, University of Otago, Dunedin, New Zealand. 2. Clinical Pharmacology, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
Abstract
Mesh： See more » Bone Density/drug effectsBone Density Conservation Agents/pharmacologyBone and Bones/drug effectsDenosumab/pharmacologyHumansModels, BiologicalPharmacology
Substances： See more » Bone Density Conservation AgentsDenosumab
Year: 2019 PMID： 31453639 DOI： 10.1002/cpt.1582
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875